Literature DB >> 22171062

Site occupancy and glycan compositional analysis of two soluble recombinant forms of the attachment glycoprotein of Hendra virus.

Michelle L Colgrave1, Hayley J Snelling, Brian J Shiell, Yan-Ru Feng, Yee-Peng Chan, Katharine N Bossart, Kai Xu, Dimitar B Nikolov, Christopher C Broder, Wojtek P Michalski.   

Abstract

Hendra virus (HeV) continues to cause morbidity and mortality in both humans and horses with a number of sporadic outbreaks. HeV has two structural membrane glycoproteins that mediate the infection of host cells: the attachment (G) and the fusion (F) glycoproteins that are essential for receptor binding and virion-host cell membrane fusion, respectively. N-linked glycosylation of viral envelope proteins are critical post-translation modifications that have been implicated in roles of structural integrity, virus replication and evasion of the host immune response. Deciphering the glycan composition and structure on these glycoproteins may assist in the development of glycan-targeted therapeutic intervention strategies. We examined the site occupancy and glycan composition of recombinant soluble G (sG) glycoproteins expressed in two different mammalian cell systems, transient human embryonic kidney 293 (HEK293) cells and vaccinia virus (VV)-HeLa cells, using a suite of biochemical and biophysical tools: electrophoresis, lectin binding and tandem mass spectrometry. The N-linked glycans of both VV and HEK293-derived sG glycoproteins carried predominantly mono- and disialylated complex-type N-glycans and a smaller population of high mannose-type glycans. All seven consensus sequences for N-linked glycosylation were definitively found to be occupied in the VV-derived protein, whereas only four sites were found and characterized in the HEK293-derived protein. We also report, for the first time, the existence of O-linked glycosylation sites in both proteins. The striking characteristic of both proteins was glycan heterogeneity in both N- and O-linked sites. The structural features of G protein glycosylation were also determined by X-ray crystallography and interactions with the ephrin-B2 receptor are discussed.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22171062      PMCID: PMC3287018          DOI: 10.1093/glycob/cwr180

Source DB:  PubMed          Journal:  Glycobiology        ISSN: 0959-6658            Impact factor:   4.313


  34 in total

Review 1.  Methods in enzymology: O-glycosylation of proteins.

Authors:  Jasna Peter-Katalinić
Journal:  Methods Enzymol       Date:  2005       Impact factor: 1.600

2.  Receptor binding, fusion inhibition, and induction of cross-reactive neutralizing antibodies by a soluble G glycoprotein of Hendra virus.

Authors:  Katharine N Bossart; Gary Crameri; Antony S Dimitrov; Bruce A Mungall; Yan-Ru Feng; Jared R Patch; Anil Choudhary; Lin-Fa Wang; Bryan T Eaton; Christopher C Broder
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

3.  Assessment of the quality and structural integrity of a complex glycoprotein mixture following extraction from the formulated biopharmaceutical drug product.

Authors:  Cuihua Liu; Shiming Dong; Xiao-Jin Xu; Yan Yin; Zachary Shriver; Ishan Capila; James Myette; Ganesh Venkataraman
Journal:  J Pharm Biomed Anal       Date:  2010-08-06       Impact factor: 3.935

4.  N-linked glycosylation of CD38 is required for its structure stabilization but not for membrane localization.

Authors:  Yin Gao; Kapil Mehta
Journal:  Mol Cell Biochem       Date:  2006-07-14       Impact factor: 3.396

5.  Structural basis of Nipah and Hendra virus attachment to their cell-surface receptor ephrin-B2.

Authors:  Thomas A Bowden; A Radu Aricescu; Robert J C Gilbert; Jonathan M Grimes; E Yvonne Jones; David I Stuart
Journal:  Nat Struct Mol Biol       Date:  2008-05-18       Impact factor: 15.369

Review 6.  Cells under siege: viral glycoprotein interactions at the cell surface.

Authors:  Thomas A Bowden; E Yvonne Jones; David I Stuart
Journal:  J Struct Biol       Date:  2011-03-31       Impact factor: 2.867

7.  Centralized modularity of N-linked glycosylation pathways in mammalian cells.

Authors:  Pan-Jun Kim; Dong-Yup Lee; Hawoong Jeong
Journal:  PLoS One       Date:  2009-10-05       Impact factor: 3.240

8.  Iterative model building, structure refinement and density modification with the PHENIX AutoBuild wizard.

Authors:  Thomas C Terwilliger; Ralf W Grosse-Kunstleve; Pavel V Afonine; Nigel W Moriarty; Peter H Zwart; Li Wei Hung; Randy J Read; Paul D Adams
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2007-12-05

Review 9.  Virus glycosylation: role in virulence and immune interactions.

Authors:  David J Vigerust; Virginia L Shepherd
Journal:  Trends Microbiol       Date:  2007-03-29       Impact factor: 17.079

Review 10.  Biological roles of oligosaccharides: all of the theories are correct.

Authors:  A Varki
Journal:  Glycobiology       Date:  1993-04       Impact factor: 4.313

View more
  20 in total

1.  Novel Functions of Hendra Virus G N-Glycans and Comparisons to Nipah Virus.

Authors:  Birgit G Bradel-Tretheway; Qian Liu; Jacquelyn A Stone; Samantha McInally; Hector C Aguilar
Journal:  J Virol       Date:  2015-05-06       Impact factor: 5.103

Review 2.  A treatment for and vaccine against the deadly Hendra and Nipah viruses.

Authors:  Christopher C Broder; Kai Xu; Dimitar B Nikolov; Zhongyu Zhu; Dimiter S Dimitrov; Deborah Middleton; Jackie Pallister; Thomas W Geisbert; Katharine N Bossart; Lin-Fa Wang
Journal:  Antiviral Res       Date:  2013-07-06       Impact factor: 5.970

3.  Hendra virus and Nipah virus animal vaccines.

Authors:  Christopher C Broder; Dawn L Weir; Peter A Reid
Journal:  Vaccine       Date:  2016-05-04       Impact factor: 3.641

4.  Nipah virus attachment glycoprotein stalk C-terminal region links receptor binding to fusion triggering.

Authors:  Qian Liu; Birgit Bradel-Tretheway; Abrrey I Monreal; Jonel P Saludes; Xiaonan Lu; Anthony V Nicola; Hector C Aguilar
Journal:  J Virol       Date:  2014-11-26       Impact factor: 5.103

Review 5.  Henipavirus outbreaks to antivirals: the current status of potential therapeutics.

Authors:  Christopher C Broder
Journal:  Curr Opin Virol       Date:  2012-03-21       Impact factor: 7.090

Review 6.  Immunization strategies against henipaviruses.

Authors:  Christopher C Broder; Thomas W Geisbert; Kai Xu; Dimitar B Nikolov; Lin-Fa Wang; Deborah Middleton; Jackie Pallister; Katharine N Bossart
Journal:  Curr Top Microbiol Immunol       Date:  2012       Impact factor: 4.291

7.  Impact of Protein Glycosylation on the Design of Viral Vaccines.

Authors:  Kathleen Schön; Bernd Lepenies; Guillaume Goyette-Desjardins
Journal:  Adv Biochem Eng Biotechnol       Date:  2021       Impact factor: 2.635

8.  Characterization of host-cell line specific glycosylation profiles of early transmitted/founder HIV-1 gp120 envelope proteins.

Authors:  Eden P Go; Hua-Xin Liao; S Munir Alam; David Hua; Barton F Haynes; Heather Desaire
Journal:  J Proteome Res       Date:  2013-02-20       Impact factor: 4.466

9.  N-Glycans on the Nipah virus attachment glycoprotein modulate fusion and viral entry as they protect against antibody neutralization.

Authors:  Scott B Biering; Andrew Huang; Andy T Vu; Lindsey R Robinson; Birgit Bradel-Tretheway; Eric Choi; Benhur Lee; Hector C Aguilar
Journal:  J Virol       Date:  2012-08-22       Impact factor: 5.103

Review 10.  Therapeutic potential of targeting the Eph/ephrin signaling complex.

Authors:  Nayanendu Saha; Dorothea Robev; Emilia O Mason; Juha P Himanen; Dimitar B Nikolov
Journal:  Int J Biochem Cell Biol       Date:  2018-10-19       Impact factor: 5.085

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.